A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-c

Schulte, Christie A.; Deaton, David N.; Diaz, Elsie; Do, Young; Gampe, Robert T.; Guss, Jeffrey H.; Hancock, Ashley P.; Hobbs, Heather; Hodgson, Simon T.; Holt, Jason; Jeune, Michael R.; Kahler, Kirsten M.; Kramer, H. Fritz; Le, Joelle; Mortenson, Paul N.; Musetti, Caterina; Nolte, Robert T.; Orband-Miller, Lisa A.; Peckham, Gregory E.; Petrov, Kim G.; Pietrak, Beth L.; Poole, Chuck; Price, Daniel J.; Saxty, Gordon; Shillings, Anthony; Smalley Jr., Terrence L.; Somers, Don O.; Stewart, Eugene L.; Stuart, J. Darren; Thomson, Stephen A.

doi:10.1016/j.bmcl.2021.128113

A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-c

Journal Article · 01 September 2021 · Bioorg. Med. Chem. Lett.

DOI:https://doi.org/10.1016/j.bmcl.2021.128113· OSTI ID:1810143

Schulte, Christie A.; Deaton, David N.; Diaz, Elsie; Do, Young; Gampe, Robert T.; Guss, Jeffrey H.; Hancock, Ashley P.; Hobbs, Heather; Hodgson, Simon T.; Holt, Jason; Jeune, Michael R.; Kahler, Kirsten M.; Kramer, H. Fritz; Le, Joelle; Mortenson, Paul N.; Musetti, Caterina; Nolte, Robert T.; Orband-Miller, Lisa A.; Peckham, Gregory E.; Petrov, Kim G. more »

Research Organization:: Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: DOE - Office Of Science; INDUSTRY

OSTI ID:: 1810143

Journal Information:: Bioorg. Med. Chem. Lett., Vol. 47

Country of Publication:: United States

Language:: ENGLISH

References (21)

Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs Vane, J. R. Nature New Biology, Vol. 231, Issue 25 https://doi.org/10.1038/newbio231232a0	journal	June 1971
Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient Laine, Loren Gastroenterology, Vol. 120, Issue 3 https://doi.org/10.1053/gast.2001.21907	journal	February 2001
Complications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac Surgery Nussmeier, Nancy A.; Whelton, Andrew A.; Brown, Mark T. New England Journal of Medicine, Vol. 352, Issue 11 https://doi.org/10.1056/NEJMoa050330	journal	March 2005
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial Bresalier, Robert S.; Sandler, Robert S.; Quan, Hui New England Journal of Medicine, Vol. 352, Issue 11 https://doi.org/10.1056/NEJMoa050493	journal	March 2005
Enzymes of the Cyclooxygenase Pathways of Prostanoid Biosynthesis Smith, William L.; Urade, Yoshihiro; Jakobsson, Per-Johan Chemical Reviews, Vol. 111, Issue 10 https://doi.org/10.1021/cr2002992	journal	October 2011
Recent reports about enzymes related to the synthesis of prostaglandin (PG) F2 (PGF2 and 9 , 11 -PGF2) Watanabe, K. Journal of Biochemistry, Vol. 150, Issue 6 https://doi.org/10.1093/jb/mvr116	journal	September 2011
Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives Kupczyk, Maciej; Kuna, Piotr Drugs, Vol. 77, Issue 12 https://doi.org/10.1007/s40265-017-0777-2	journal	June 2017
Fragment Based Drug Discovery Using Fluorescence Correlation Spectroscopy Techniques: Challenges and Solutions Hesterkamp, T.; Barker, J.; Davenport, A. Current Topics in Medicinal Chemistry, Vol. 7, Issue 16 https://doi.org/10.2174/156802607782341064	journal	August 2007
Novel Prostaglandin D Synthase Inhibitors Generated by Fragment-Based Drug Design ^† Hohwy, Morten; Spadola, Loredana; Lundquist, Britta Journal of Medicinal Chemistry, Vol. 51, Issue 7 https://doi.org/10.1021/jm701509k	journal	April 2008
Demonstration on Pilot-Plant Scale of the Utility of 1,5,7-Triazabicyclo[4.4.0]dec-5-ene (TBD) as a Catalyst in the Efficient Amidation of an Unactivated Methyl Ester Weiberth, Franz J.; Yu, Yong; Subotkowski, Witold Organic Process Research & Development, Vol. 16, Issue 12 https://doi.org/10.1021/op300210j	journal	October 2012
Discovery of an Oral Potent Selective Inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS) Carron, Chris P.; Trujillo, John I.; Olson, Kirk L. ACS Medicinal Chemistry Letters, Vol. 1, Issue 2 https://doi.org/10.1021/ml900025z	journal	February 2010
Early phase 2 trial of TAS‐205 in patients with Duchenne muscular dystrophy Komaki, Hirofumi; Maegaki, Yoshihiro; Matsumura, Tsuyoshi Annals of Clinical and Translational Neurology, Vol. 7, Issue 2 https://doi.org/10.1002/acn3.50978	journal	January 2020
A phase I study of TAS-205 in patients with Duchenne muscular dystrophy Takeshita, Eri; Komaki, Hirofumi; Shimizu-Motohashi, Yuko Annals of Clinical and Translational Neurology, Vol. 5, Issue 11 https://doi.org/10.1002/acn3.651	journal	October 2018
Automated assays for thermodynamic (equilibrium) solubility determination Sou, Tomás; Bergström, Christel A. S. Drug Discovery Today: Technologies, Vol. 27 https://doi.org/10.1016/j.ddtec.2018.04.004	journal	July 2018
Molecular Properties That Influence the Oral Bioavailability of Drug Candidates Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan Journal of Medicinal Chemistry, Vol. 45, Issue 12 https://doi.org/10.1021/jm020017n	journal	June 2002
Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes Kansy, Manfred; Senner, Frank; Gubernator, Klaus Journal of Medicinal Chemistry, Vol. 41, Issue 7 https://doi.org/10.1021/jm970530e	journal	March 1998
Ligand efficiency: a useful metric for lead selection Hopkins, Andrew L.; Groom, Colin R.; Alex, Alexander Drug Discovery Today, Vol. 9, Issue 10 https://doi.org/10.1016/S1359-6446(04)03069-7	journal	May 2004
Identification of orally bioavailable small-molecule inhibitors of hematopoietic prostaglandin D2 synthase using X-ray fragment based drug discovery Saxty, Gordon; Norton, David; Affleck, Karen Med. Chem. Commun., Vol. 5, Issue 2 https://doi.org/10.1039/C3MD00280B	journal	January 2014
The discovery of quinoline-3-carboxamides as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors Deaton, David N.; Do, Young; Holt, Jason Bioorganic & Medicinal Chemistry, Vol. 27, Issue 8 https://doi.org/10.1016/j.bmc.2019.02.017	journal	April 2019
Drug-like properties and the causes of poor solubility and poor permeability Lipinski, Christopher A. Journal of Pharmacological and Toxicological Methods, Vol. 44, Issue 1 https://doi.org/10.1016/S1056-8719(00)00107-6	journal	July 2000
BDDCS, the Rule of 5 and drugability Benet, Leslie Z.; Hosey, Chelsea M.; Ursu, Oleg Advanced Drug Delivery Reviews, Vol. 101 https://doi.org/10.1016/j.addr.2016.05.007	journal	June 2016

Similar Records

Discovery of 1-[3-(1-Methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron Dual Kinase Inhibitor with Preferential Affinity for the Activated State of c-Met

Journal Article · 2013 · J. Med. Chem. · OSTI ID:1078048

Northrup, Alan B.; Katcher, Matthew H.; Altman, Michael D.; +22 more

Malignant transformation of human colon epithelial cells by benzo[c]phenanthrene dihydrodiolepoxides as well as 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine

Journal Article · 2006 · Toxicology and Applied Pharmacology · OSTI ID:20783461

Herbst, Uta; Fuchs, Judith Iris; Teubner, Wera; +1 more

Comparison of crystal structure and theory for 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine

Journal Article · 1996 · Chemical Research in Toxicology · OSTI ID:589049

Parkin, S; Marsch, G A; Winter, N W

A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-c

Citation Formats

References (21)

Similar Records

Related Subjects